Literature DB >> 26675706

Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation.

Gwanghyun Jung1, Giovanni Fajardo1, Alexandre J S Ribeiro1, Kristina Bezold Kooiker1, Michael Coronado1, Mingming Zhao1, Dong-Qing Hu1, Sushma Reddy1, Kazuki Kodo1, Krishna Sriram1, Paul A Insel1, Joseph C Wu1, Beth L Pruitt1, Daniel Bernstein2.   

Abstract

Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a powerful platform for uncovering disease mechanisms and assessing drugs for efficacy/toxicity. However, the accuracy with which hiPSC-CMs recapitulate the contractile and remodeling signaling of adult cardiomyocytes is not fully known. We used β-adrenergic receptor (β-AR) signaling as a prototype to determine the evolution of signaling component expression and function during hiPSC-CM maturation. In "early" hiPSC-CMs (less than or equal to d 30), β2-ARs are a primary source of cAMP/PKA signaling. With longer culture, β1-AR signaling increases: from 0% of cAMP generation at d 30 to 56.8 ± 6.6% by d 60. PKA signaling shows a similar increase: 15.7 ± 5.2% (d 30), 49.8 ± 0.5% (d 60), and 71.0 ± 6.1% (d 90). cAMP generation increases 9-fold from d 30 to 60, with enhanced coupling to remodeling pathways (e.g., Akt and Ca(2+)/calmodulin-dependent protein kinase type II) and development of caveolin-mediated signaling compartmentalization. By contrast, cardiotoxicity induced by chronic β-AR stimulation, a major component of heart failure, develops much later: 5% cell death at d 30vs 55% at d 90. Moreover, β-AR maturation can be accelerated by biomechanical stimulation. The differential maturation of β-AR functionalvs remodeling signaling in hiPSC-CMs has important implications for their use in disease modeling and drug testing. We propose that assessment of signaling be added to the indices of phenotypic maturation of hiPSC-CMs.-Jung, G., Fajardo, G., Ribeiro, A. J. S., Kooiker, K. B., Coronado, M., Zhao, M., Hu, D.-Q., Reddy, S., Kodo, K., Sriram, K., Insel, P. A., Wu, J. C., Pruitt, B. L., Bernstein, D. Time-dependent evolution of functionalvs remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation. © FASEB.

Entities:  

Keywords:  cardiotoxicity testing; cell signaling maturation; β-adrenergic receptor

Mesh:

Substances:

Year:  2015        PMID: 26675706      PMCID: PMC4799510          DOI: 10.1096/fj.15-280982

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  59 in total

1.  Inhibition of spontaneous beta 2-adrenergic activation rescues beta 1-adrenergic contractile response in cardiomyocytes overexpressing beta 2-adrenoceptor.

Authors:  S J Zhang; H Cheng; Y Y Zhou; D J Wang; W Zhu; B Ziman; H Spurgoen; R J Lefkowitz; E G Lakatta; W J Koch; R P Xiao
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

2.  Physiologic force-frequency response in engineered heart muscle by electromechanical stimulation.

Authors:  Amandine F G Godier-Furnémont; Malte Tiburcy; Eva Wagner; Matthias Dewenter; Simon Lämmle; Ali El-Armouche; Stephan E Lehnart; Gordana Vunjak-Novakovic; Wolfram-Hubertus Zimmermann
Journal:  Biomaterials       Date:  2015-05-15       Impact factor: 12.479

3.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

4.  CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation.

Authors:  Stefan Neef; Nataliya Dybkova; Samuel Sossalla; Katharina R Ort; Nina Fluschnik; Kay Neumann; Ralf Seipelt; Friedrich A Schöndube; Gerd Hasenfuss; Lars S Maier
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

5.  beta-Arrestin-dependent activation of Ca(2+)/calmodulin kinase II after beta(1)-adrenergic receptor stimulation.

Authors:  Supachoke Mangmool; Arun K Shukla; Howard A Rockman
Journal:  J Cell Biol       Date:  2010-04-26       Impact factor: 10.539

6.  Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure.

Authors:  A Kaumann; S Bartel; P Molenaar; L Sanders; K Burrell; D Vetter; P Hempel; P Karczewski; E G Krause
Journal:  Circulation       Date:  1999 Jan 5-12       Impact factor: 29.690

Review 7.  The structure and function of G-protein-coupled receptors.

Authors:  Daniel M Rosenbaum; Søren G F Rasmussen; Brian K Kobilka
Journal:  Nature       Date:  2009-05-21       Impact factor: 49.962

8.  Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.

Authors:  Stefan Engelhardt; Lutz Hein; Vitaly Dyachenkow; Evangelia G Kranias; Gerrit Isenberg; Martin J Lohse
Journal:  Circulation       Date:  2004-02-16       Impact factor: 29.690

Review 9.  What is the role of beta-adrenergic signaling in heart failure?

Authors:  Martin J Lohse; Stefan Engelhardt; Thomas Eschenhagen
Journal:  Circ Res       Date:  2003-11-14       Impact factor: 17.367

10.  The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.

Authors:  Christopher Rao; Themistoklis Prodromakis; Ljudmila Kolker; Umar A R Chaudhry; Tatiana Trantidou; Arun Sridhar; Claire Weekes; Patrizia Camelliti; Sian E Harding; Ara Darzi; Magdi H Yacoub; Thanos Athanasiou; Cesare M Terracciano
Journal:  Biomaterials       Date:  2012-12-20       Impact factor: 12.479

View more
  30 in total

1.  Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.

Authors:  Oscar J Abilez; Evangeline Tzatzalos; Huaxiao Yang; Ming-Tao Zhao; Gwanghyun Jung; Alexander M Zöllner; Malte Tiburcy; Johannes Riegler; Elena Matsa; Praveen Shukla; Yan Zhuge; Tony Chour; Vincent C Chen; Paul W Burridge; Ioannis Karakikes; Ellen Kuhl; Daniel Bernstein; Larry A Couture; Joseph D Gold; Wolfram H Zimmermann; Joseph C Wu
Journal:  Stem Cells       Date:  2017-11-13       Impact factor: 6.277

2.  Coculture of Endothelial Cells with Human Pluripotent Stem Cell-Derived Cardiac Progenitors Reveals a Differentiation Stage-Specific Enhancement of Cardiomyocyte Maturation.

Authors:  Kaitlin K Dunn; Isabella M Reichardt; Aaron D Simmons; Gyuhyung Jin; Martha E Floy; Kelsey M Hoon; Sean P Palecek
Journal:  Biotechnol J       Date:  2019-05-14       Impact factor: 4.677

Review 3.  High throughput physiological screening of iPSC-derived cardiomyocytes for drug development.

Authors:  Juan C Del Álamo; Derek Lemons; Ricardo Serrano; Alex Savchenko; Fabio Cerignoli; Rolf Bodmer; Mark Mercola
Journal:  Biochim Biophys Acta       Date:  2016-03-04

4.  Induced Pluripotent Stem Cell-Derived Cardiomyocytes: A Platform for Testing For Drug Cardiotoxicity.

Authors:  Daniel Bernstein
Journal:  Prog Pediatr Cardiol       Date:  2017-07-18

Review 5.  GPCRomics: An Approach to Discover GPCR Drug Targets.

Authors:  Paul A Insel; Krishna Sriram; Matthew W Gorr; Shu Z Wiley; Alexander Michkov; Cristina Salmerón; Amy M Chinn
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

6.  Targeting HIF-1α in combination with PPARα activation and postnatal factors promotes the metabolic maturation of human induced pluripotent stem cell-derived cardiomyocytes.

Authors:  Cinsley Gentillon; Dong Li; Meixue Duan; Wen-Mei Yu; Marcela K Preininger; Rajneesh Jha; Antonio Rampoldi; Anita Saraf; Gregory C Gibson; Cheng-Kui Qu; Lou Ann Brown; Chunhui Xu
Journal:  J Mol Cell Cardiol       Date:  2019-05-11       Impact factor: 5.000

7.  Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair.

Authors:  Malte Tiburcy; James E Hudson; Paul Balfanz; Susanne Schlick; Tim Meyer; Mei-Ling Chang Liao; Elif Levent; Farah Raad; Sebastian Zeidler; Edgar Wingender; Johannes Riegler; Mouer Wang; Joseph D Gold; Izhak Kehat; Erich Wettwer; Ursula Ravens; Pieterjan Dierickx; Linda W van Laake; Marie Jose Goumans; Sara Khadjeh; Karl Toischer; Gerd Hasenfuss; Larry A Couture; Andreas Unger; Wolfgang A Linke; Toshiyuki Araki; Benjamin Neel; Gordon Keller; Lior Gepstein; Joseph C Wu; Wolfram-Hubertus Zimmermann
Journal:  Circulation       Date:  2017-02-06       Impact factor: 29.690

Review 8.  Ca2+ signaling of human pluripotent stem cells-derived cardiomyocytes as compared to adult mammalian cardiomyocytes.

Authors:  Xiao-Hua Zhang; Martin Morad
Journal:  Cell Calcium       Date:  2020-06-13       Impact factor: 6.817

Review 9.  Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.

Authors:  Shi Hua Tan; Lei Ye
Journal:  J Cardiovasc Transl Res       Date:  2018-03-19       Impact factor: 4.132

Review 10.  Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.

Authors:  Tarek Magdy; Adam J T Schuldt; Joseph C Wu; Daniel Bernstein; Paul W Burridge
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.